HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness (Dietary Supplements)

Set Alert for Wellness

Regulation / Legislation Explore this Topic

Set Alert for Regulation and Legislation {Wellness}

Latest From Regulation & Wellness

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

Studies Find Oil, Topical And Transdermal Hemp Products’ Content Inconsistent With Labeling

JAMA study found 24% of 89 topicals or transdermals labeled correctly for amounts of cannabinoid in the products; JCR study found 54% of 80 CBD oils were accurately labeled, 15% had higher levels and 31% had lower.

FDA Cannabidiol CBD

House Members Object To Senate Adding Supplement MPL Proposal In FDA User Fee Bill

Members led by SC Republican Jeff Duncan and CA Democrat Tony Cárdenas, in letter to House speaker and minority leader, oppose MPL provision in latest version of S.4348 for re-authorizing FDA drug, biologic and medical device user fee programs.

Dietary Supplements FDA
See All

Latest From Legislation & Wellness

Studies Find Oil, Topical And Transdermal Hemp Products’ Content Inconsistent With Labeling

JAMA study found 24% of 89 topicals or transdermals labeled correctly for amounts of cannabinoid in the products; JCR study found 54% of 80 CBD oils were accurately labeled, 15% had higher levels and 31% had lower.

FDA Cannabidiol CBD

House Members Object To Senate Adding Supplement MPL Proposal In FDA User Fee Bill

Members led by SC Republican Jeff Duncan and CA Democrat Tony Cárdenas, in letter to House speaker and minority leader, oppose MPL provision in latest version of S.4348 for re-authorizing FDA drug, biologic and medical device user fee programs.

Dietary Supplements FDA

Mandatory Product Listing: Needed For US VMS Market, Not Mandatory In User Fee Bill – CRN

Establishing VMS products MPL as stated within legislation to re-authorize FDA user fee programs for drugs, biologics and medical device applications isn’t urgent enough to prevent passing user fee bill, says CRN chief Steve Mister.

Dietary Supplements FDA
See All

Business Explore this Topic

Set Alert for Business {Wellness}

Latest From Deals & Wellness

Dermapharm Expands Natural Offering With France's Arkopharma

Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.

Deals Europe

GSK Exits Consumer Health With Haleon Launch

The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.

Business Strategies Deals

Mayoly Spindler Enhances Natural Supplements Offering With Pharm Nature

France's Mayoly Spindler is expanding its offering in its local dietary supplements market by acquiring Pharm Nature Micronutrition which specializes in natural products based on organic ingredients.

France Deals
See All

Latest From Business Strategies & Wellness

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

DSM Overcomes Supply Chain Challenges To Post First-Half Sales Gain

Heerlen, Netherlands-based DSM posted a double-digit rise in sales at its Health, Nutrition and Care operation in the first half despite facing a "continuous battle" to place and receive deliveries.

Sales & Earnings Dietary Supplements

House Members Object To Senate Adding Supplement MPL Proposal In FDA User Fee Bill

Members led by SC Republican Jeff Duncan and CA Democrat Tony Cárdenas, in letter to House speaker and minority leader, oppose MPL provision in latest version of S.4348 for re-authorizing FDA drug, biologic and medical device user fee programs.

Dietary Supplements FDA
See All

Latest From Sales & Earnings & Wellness

DSM Overcomes Supply Chain Challenges To Post First-Half Sales Gain

Heerlen, Netherlands-based DSM posted a double-digit rise in sales at its Health, Nutrition and Care operation in the first half despite facing a "continuous battle" to place and receive deliveries.

Sales & Earnings Dietary Supplements

Inflation, Supply Chain And Private Label Pressures: Consumer Health Leaders Talk ‘Big Picture’ Challenges

OTC drug and dietary supplement companies continue to face significant economic and competitive issues in what continues to be a highly volatile operating environment. Here we’ve culled takes from top execs at Sanofi, Bayer, J&J, P&G and other leading players, provided during recent sales and earnings presentations.

Business Strategies Supply Chain

Perrigo Starts Supply Chain Overhaul After Filing OTC Birth Control NDA, Launching Nasonex Switch

Along with Q2 results including reported net sales up 14.3% to $1.12bn, Perrigo announces overhaul of its supply chain expected to generate $100m to $300m in net cost savings and creation of women's health, skin care business units.

Sales & Earnings Supply Chain
See All

Latest From Legal Issues & Wellness

First Recalls, Now Investors' Concerns Over Ranitidine Litigation Take Pharmas For Wild Ride

Host of complaints in US courts, seeking damages or alleging ranitidine caused various cancers, followed FDA’s 2020 findings of NDMA levels exceeding allowable limits in some samples provoked  Litigation is starting to come to trial, the first set for 22 August in Illinois and a bellwether case due to begin in California in February 2023.

Recalls OTC Drugs

If US Court Says Delta-8 Product Is Lawful And Trademark Valid, Will Federal Agencies Listen?

Recent 9th Circuit ruling upheld granting a firm preliminary injunction stopping competitor from using its trademarked brand for delta-8 THC products. Ruling generally runs counter to USPTO policy against accepting trademark registrations for hemp or cannabis products and specifically counters FDA stance delta-8 doesn’t meet definition of hemp under 2018 farm bill.

Cannabidiol CBD Legal Issues

CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate

Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.

Cannabidiol CBD FDA
See All

Marketing Explore this Topic

Set Alert for Marketing {Wellness}

Latest From Launches & Wellness

HBW Product Launches: Preminity, Dr. Formulated, Clear Focus, Zicam Immune, Synergy Plus

Garden of Life offers Triple Action Dr. Formulated; BasicBites Synergy Plus for oral care; Zicam extends to Daily Immune Support and Sleep + Immune Support with melatonin; Novastell launches Preminity for PMS; Prunelax in gummy; and lion’s mane mushroom in Clear Focus.

Launches Dietary Supplements

Health And Wellness Weekly Trademarks Review: 2 August

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

Herbalife's 10.3% Slump Tracks With Full-Year Guidance But Light Seen At The End Of 2022

Herbalife reported a double digit decrease in net sales during its second quarter, following similar results in the first quarter. The direct seller also plans to launch its digital platform Herbalife One to connect distributers and consumers and promote sales.

Sales & Earnings Dietary Supplements
See All

Latest From Ad Campaigns & Wellness

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

Less Than Four Weeks Remain To Enter The OTC Marketing Awards 2022

Entries to the OTC Marketing Awards are coming in thick and fast from industry players large and small across the 15 categories. With the entry deadline fast approaching on 29 August, don't miss out on your chance to win a prestigious trophy. 

Ad Campaigns Innovation

HBW US Market News: FTC Returns 'Free Trial' Losses, Old Spice Targets 'Meat Sweats,' More

FTC returns more than $5.4m to more than 100,000 consumers from "free trial" scam;" Hood College names Nutrition Science Program's founding director; Cremer introduces gummy-counting machine; Herbalife renovates LA headquarters; Arby's and Old Spice team up to fight "meat sweats."

Ad Campaigns Consumer
See All

Latest From Ad Complaints & Wellness

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

Responsibility For Distributors’ Claims At Root Of Supplement Direct Seller’s Advertising Review

After the DSSRC recommended that Root Wellness remove health claims from its advertising in 2021, the direct seller has not made efforts to remove the claims that its ambassadors have made on social media.

Regulation Enforcement

Sanofi Appealing Findings In Review Of Zantac 360 Doctor-Recommended Claims Challenged By J&J

French pharma disagrees with NAD finding, following review of a claims made in online and social media ads, retailers' websites and a TV commercial, that the claim “#1 doctor recommended medicine” for Zantac 360 refers to the brand and not famotidine, also used in other OTC heartburn remedies, including Pepcid.

Ad Complaints OTC Drugs
See All
UsernamePublicRestriction

Register